IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,194 | -75.8% | 35,638 | -73.2% | 0.01% | -76.2% |
| Q2 2023 | $1,416,195 | +1.5% | 133,101 | +0.4% | 0.02% | -4.5% |
| Q1 2023 | $1,394,868 | -11.7% | 132,592 | +4.0% | 0.02% | -15.4% |
| Q4 2022 | $1,578,957 | +60.0% | 127,438 | +33.8% | 0.03% | +36.8% |
| Q3 2022 | $987,000 | +258.9% | 95,276 | +299.5% | 0.02% | +280.0% |
| Q2 2022 | $275,000 | +11.3% | 23,850 | +21.2% | 0.01% | +25.0% |
| Q1 2022 | $247,000 | +6.9% | 19,672 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $231,000 | 0.0% | 19,852 | +12.4% | 0.00% | -20.0% |
| Q3 2021 | $231,000 | +35.1% | 17,657 | +32.9% | 0.01% | +66.7% |
| Q2 2021 | $171,000 | +15.5% | 13,289 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $148,000 | -2.0% | 13,289 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $151,000 | +55.7% | 13,289 | +23.3% | 0.00% | +33.3% |
| Q3 2020 | $97,000 | -12.6% | 10,780 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $111,000 | – | 10,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |